Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of Endourology 2015-May

Laser ablation in the management of obstructive uropathy in neonates.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
Matthew J Pagano
Jason P van Batavia
Pasquale Casale

キーワード

概要

BACKGROUND

Endoscopic management of posterior urethral valves and congenital ureteroceles is the current standard to relieve the obstruction. While the most commonly used techniques involve cystoscopic incision with cold knife or electrosurgery, an alternative is to ablate the obstructive tissue with laser energy. With increasing prenatal diagnoses, there has been an increasing shift in the timing of intervention toward earlier periods. The literature contains only two reports of laser ablation in neonates for these disease entities.

METHODS

A case series was conducted by retrospectively reviewing our surgical database for all consecutive infants <28 days old (i.e., neonates) diagnosed in utero with obstructive uropathy and with postnatal imaging consistent with either urethral valves (anterior or posterior) or ureterocele. Holmium: yttrium aluminum-garnet (Ho:YAG) laser ablation was used as the exclusive modality of endoscopic management during the study period. All patients were followed with voiding cystourethrogram and renal/bladder ultrasounds postoperatively.

RESULTS

Seventeen neonates underwent retrograde transurethral laser ablation procedures at a median age of 7 days (range 3-27). There were nine cases of urethral valve ablation (seven posterior, two anterior) and eight ureterocele ablations. Median operative time was 23 minutes (range 18-33). There were no intraoperative complications or reoperative procedures required for any case. All patients voided after postoperative catheter removal, and no patient had evidence of residual valve tissue or urethral stricture at mean follow-up of 10.1 months. All patients with ureterocele demonstrated partial or complete decompression of the ureterocele and improvement in hydroureteronephrosis at 3 months.

CONCLUSIONS

Ho:YAG laser ablation appears safe, effective, and efficient for the management of urethral valves and ureteroceles in the neonatal period. With a continuing trend toward early definitive intervention for these conditions, laser ablation remains an important alternative to electrosurgery in this population.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge